Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 18
ISSN: 1178-7066
- View all (677)
- Volume 18, 2025 (12)
- Volume 17, 2024 (44)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 18, 2025
Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
Chen Q, Zhang W, Zha L
Pharmacogenomics and Personalized Medicine 2025, 18:153-162
Published Date: 17 June 2025
Associations Between FTO Polymorphisms and Neuroblastoma Risk in Chinese Children
Liu P, Li Y, Li Y, Li L, Cheng J, Li S, Zhang J, Zhou H, Huo Y, Yang Z, He J, Zhang R
Pharmacogenomics and Personalized Medicine 2025, 18:143-151
Published Date: 27 May 2025
Quercetin Inhibits Gastric Cancer Progression via FAM198B/MAPK Pathway Modulation
Deng H, Xiao Q, Xu X, Zhang L, Zhang Y
Pharmacogenomics and Personalized Medicine 2025, 18:115-141
Published Date: 15 May 2025
Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China
Li XP, Wang JL, Lei SX, Chen BY, Ma X, He F, Yue CF, Liu HX, Hu JP, Xiong Q, Ji T, Zhang ZF, Sun Y, Li HW
Pharmacogenomics and Personalized Medicine 2025, 18:105-113
Published Date: 2 May 2025
Clinicopathological and Molecular Features of Primary Inflammatory Myofibroblastic Tumor in Nasal Cavity and Paranasal Sinuses
Zhao Y, Ma D, Wan H, Piao Y
Pharmacogenomics and Personalized Medicine 2025, 18:95-104
Published Date: 28 April 2025
Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screening
Lin P, Liu H, Lou J, Lyu G, Li Y, He P, Fu Y, Zhang R, Zhang Y, Yan T
Pharmacogenomics and Personalized Medicine 2025, 18:85-94
Published Date: 23 April 2025
Association of MiRNA Polymorphisms Involved in the PI3K/ATK/GSK3β Pathway with T2DM in a Chinese Population
Zhou X, Yang M, Yang Y, Xu F, Wang F, Jiao M, Tao W, Li Y
Pharmacogenomics and Personalized Medicine 2025, 18:71-84
Published Date: 14 February 2025
Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review
Katabalo DM, Mwita S, Liwa AC, Kidenya BR, Schroeder K
Pharmacogenomics and Personalized Medicine 2025, 18:55-69
Published Date: 14 February 2025
A Novel Pathogenic Splicing Mutation of OFD1 is Responsible for a Boy with Joubert Syndrome Exhibiting Orofaciodigital Spectrum Anomalies, Polydactyly and Retinitis Pigmentosa
Chen L, Zhao MF, Deng HW, Liao M, Fan LL, Zhong QB, Wang J, Li K, Wu ZH, Yin JY
Pharmacogenomics and Personalized Medicine 2025, 18:47-53
Published Date: 3 February 2025
Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
Luo X, Chen L, Xu J, Li J
Pharmacogenomics and Personalized Medicine 2025, 18:35-46
Published Date: 31 January 2025
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
Borbón A, Briceño JC, Valderrama-Aguirre A
Pharmacogenomics and Personalized Medicine 2025, 18:19-34
Published Date: 30 January 2025
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder
He Y, He Y, Cheng B
Pharmacogenomics and Personalized Medicine 2025, 18:1-18
Published Date: 17 January 2025